BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 34277822)

  • 1. Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients.
    Cheng L; Yuan M; Li S; Lian Z; Chen J; Lin W; Zhang J; Zhong S
    Ann Transl Med; 2021 Jun; 9(11):925. PubMed ID: 34350240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma.
    Ma C; Li F; Luo H
    Ann Transl Med; 2021 Jul; 9(13):1058. PubMed ID: 34422970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
    Zhang M; Zhang X; Yu M; Zhang W; Zhang D; Zeng S; Wang X; Hu X
    Front Oncol; 2021; 11():698856. PubMed ID: 34386423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
    Luan JC; Zeng TY; Zhang QJ; Xia DR; Cong R; Yao LY; Song LB; Zhou X; Zhou X; Chen X; Xia JD; Song NH
    Cancer Cell Int; 2021 Aug; 21(1):414. PubMed ID: 34362387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
    Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
    Front Oncol; 2021; 11():686044. PubMed ID: 34422642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level.
    Wu Y; Yang S; Ma J; Chen Z; Song G; Rao D; Cheng Y; Huang S; Liu Y; Jiang S; Liu J; Huang X; Wang X; Qiu S; Xu J; Xi R; Bai F; Zhou J; Fan J; Zhang X; Gao Q
    Cancer Discov; 2022 Jan; 12(1):134-153. PubMed ID: 34417225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biomarkers for acute leukemia via machine learning-based stemness index.
    Zhang Y; Liu D; Li F; Zhao Z; Liu X; Gao D; Zhang Y; Li H
    Gene; 2021 Dec; 804():145903. PubMed ID: 34411647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunogenomic signature for molecular classification in hepatocellular carcinoma.
    Zhuang W; Sun H; Zhang S; Zhou Y; Weng W; Wu B; Ye T; Huang W; Lin Z; Shi L; Shi K
    Mol Ther Nucleic Acids; 2021 Sep; 25():105-115. PubMed ID: 34401208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Ferroptosis-Mediated Modification Patterns and Tumor Immune Microenvironment Characterization in Uveal Melanoma.
    Jin Y; Wang Z; He D; Zhu Y; Gong L; Xiao M; Chen X; Cao K
    Front Cell Dev Biol; 2021; 9():685120. PubMed ID: 34386492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune implication of an autophagy-related prognostic signature in uveal melanoma.
    Chuah S; Chew V
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34374416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer.
    Xiong H; Gao H; Hu J; Dai Y; Wang H; Fu M; Qi T; Li L; Xia Q; Jin X; Cui Z; Kang W
    J Oncol; 2021; 2021():5345181. PubMed ID: 34354750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma.
    Guo Y; Qu Z; Li D; Bai F; Xing J; Ding Q; Zhou J; Yao L; Xu Q
    Cell Death Discov; 2021 Jul; 7(1):190. PubMed ID: 34312372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy.
    Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Ikeuchi Y; Kozuka Y; Idogawa M; Hirohashi Y; Torigoe T; Iwasaki M; Matsuura M; Saito T; Sakata KI
    Med Mol Morphol; 2023 Mar; 56(1):38-45. PubMed ID: 36367588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variations of
    Xi M; Zhang G; Wang L; Chen H; Gao L; Zhang L; Yang Z; Shi H
    Pharmgenomics Pers Med; 2022; 15():487-497. PubMed ID: 35592549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a prognostic-related microRNAs risk model for glioma by bioinformatics analysis.
    Wang Y; Zhang C; Lu W; Chen R; Yu M
    Ann Transl Med; 2021 Jun; 9(12):1022. PubMed ID: 34277822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
    Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNAs Mediate GDNF-Induced Proliferation and Migration of Glioma Cells.
    Zhang BL; Dong FL; Guo TW; Gu XH; Huang LY; Gao DS
    Cell Physiol Biochem; 2017; 44(5):1923-1938. PubMed ID: 29224008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a novel microRNA-based signature for predicting the prognosis of glioma.
    Liu G; Rong X; Lin X; Wang H; He L; Peng Y
    Int J Neurosci; 2023 Dec; 133(8):840-850. PubMed ID: 35353669
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.